New surgical stapler shows promise in lung cancer operations

NCT ID NCT07354854

Completed Disease control Sponsor: Ezisurg Medical Co. Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new surgical stapler (easyEndo™ Lite) in 30 people undergoing lung cancer surgery. The goal was to see if the device safely cuts and seals lung tissue. Researchers checked for successful sealing, surgery time, blood loss, and complications. The study is complete, but results are not yet widely available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: easyEndo™ Lite Linear Cutting Stapler (device)
What this could lead to: If successful, this could confirm that the stapler is a safe and effective tool for lung surgery, potentially improving surgical outcomes.
What could go wrong: This is a small, completed study with only 30 participants, so results may not apply to all patients. There are standard surgical risks like bleeding or air leaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER (DIAGNOSIS)

Contacts and locations

Locations

Jinhua Municipal Central Hospital

Jinhua, Zhejiang, 321000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.